UnitedHealth Group acquires Genoa Healthcare for $2.5B

Anicka Slachta | | Health Exec | Policy & Regulations
Money

UnitedHealth Group, the U.S.’s largest health insurer, last week bought pharmacy company Genoa Healthcare for $2.5 billion, Bloomberg reports.

A source familiar with the private talks told Bloomberg UnitedHealth beat other interested parties to the deal, including Walgreens Boots Alliance, which was reportedly interested in Genoa several months ago. Genoa runs more than 425 pharmacies in behavioral health centers across 46 states, serving an estimated 650,000 patients.

Genoa will be wrapped into UnitedHealth’s pharmacy benefit group, OptumRx, with the goal of improving care for patients with mental health and substance abuse issues. The company was bought through Advent International, a private equity firm that bought an 80 percent stake in Genoa in 2015.

Read the full report from Bloomberg below:

UnitedHealth Purchases Pharmacy Genoa Healthcare From Advent

""
Anicka Slachta

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.